Glenmark Pharmaceuticals expands ophthalmic portfolio with new Travoprost Ophthalmic Solution

In a significant move to bolster its position in the United States generics market, Glenmark Pharmaceuticals Inc., USA has launched Travoprost Ophthalmic Solution USP, 0.004% ... Read More